Analyst Ratings for Emergent BioSolutions (EBS)

EBS Rating Summary

EBS Price Target Summary

* Over Last 12-Mos
  |   Expand Research on EBS
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $47.00 (+22%) * Over Last 12-Mos
Rating Score: 8.9 / 10   Percentile Rank: 91%
Date Firm Type Rating
(Past)
PT
(Past)
Start $ End $ % Chg. Details
4/15/2016 Chardan Capital Markets New Coverage Buy
(N/A)
47.00
(N/A)
38.70 38.52 -0.47% Details
2/19/2016 Wells Fargo New Coverage Outperform
(N/A)
N/A
(N/A)
37.22 38.52 3.49% Details
Like EBS Ratings? Also take a look at LGND, EFOI, SCLN, XON

EBS Ratings News